SAHS is an acronym that stands for Subacute Sclerosing Panencephalitis, a rare neurological disorder predominantly affecting children and adolescents. This condition is caused by a persistent infection of the brain with the measles virus. The term "subacute" refers to the slow and progressive nature of the disease, while "sclerosing" indicates the formation of scar tissue in the brain.
SAHS is characterized by a range of symptoms that typically emerge several years after a person has had a measles infection. These symptoms include cognitive decline, behavioral changes, seizures, muscle stiffness, involuntary jerking movements, and loss of motor skills. As SAHS progresses, individuals often experience deterioration in cognitive and intellectual abilities, including memory loss, confusion, and disorientation. Eventually, individuals with SAHS may become bedridden and may require full-time care.
Unfortunately, there is currently no cure for SAHS, and treatment options are limited to managing the symptoms and providing supportive care. Antiviral medications may be used to slow down the progression of the disease, but their effectiveness is often limited. In advanced stages, individuals with SAHS may require medications to control seizures, physical therapy to maintain muscle function, and supportive measures to ensure their comfort and quality of life.
In conclusion, SAHS refers to Subacute Sclerosing Panencephalitis, a rare neurological disorder caused by a persistent infection of the brain with the measles virus. It is a progressive disease characterized by cognitive decline, behavioral changes, seizures, and loss of motor skills, for which there is currently no cure.
